A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
7 Hills Pharma, LLC
Essen Biotech
Takeda
Kidney Cancer Research Bureau
Second Life Therapeutics
Hadassah Medical Organization
A2 Biotherapeutics Inc.
Sensei Biotherapeutics, Inc.
ModeX Therapeutics, An OPKO Health Company
Cancer Research UK
Nimbus Therapeutics
Kineta Inc.
National Institutes of Health Clinical Center (CC)
Novartis
Masonic Cancer Center, University of Minnesota
Amgen
Memorial Sloan Kettering Cancer Center
Mirror Biologics, Inc.